393 related articles for article (PubMed ID: 26979596)
1. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.
Bhat ZY; Cadnapaphornchai P; Ginsburg K; Sivagnanam M; Chopra S; Treadway CK; Lin HS; Yoo G; Sukari A; Doshi MD
PLoS One; 2015; 10(11):e0142225. PubMed ID: 26556481
[TBL] [Abstract][Full Text] [Related]
3. Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
McMahon KR; Harel-Sterling M; Pizzi M; Huynh L; Hessey E; Zappitelli M
Pediatr Nephrol; 2018 Dec; 33(12):2311-2320. PubMed ID: 30218190
[TBL] [Abstract][Full Text] [Related]
4. Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients.
Ishitsuka R; Miyazaki J; Ichioka D; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Matsui Y; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Kawai K; Nishiyama H
Clin Exp Nephrol; 2017 Aug; 21(4):732-740. PubMed ID: 27565169
[TBL] [Abstract][Full Text] [Related]
5. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
Shoji S; Hosojima M; Kabasawa H; Kondo R; Miura S; Watanabe S; Aoki N; Kaseda R; Kuwahara S; Tanabe N; Hirayama Y; Narita I; Kikuchi T; Kagamu H; Saito A
BMC Cancer; 2019 Dec; 19(1):1170. PubMed ID: 31791266
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Renal Outcomes after Cisplatin Treatment.
Latcha S; Jaimes EA; Patil S; Glezerman IG; Mehta S; Flombaum CD
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1173-1179. PubMed ID: 27073199
[TBL] [Abstract][Full Text] [Related]
7. Lower Blood Pressure-Induced Renal Hypoperfusion Promotes Cisplatin-Induced Nephrotoxicity.
Mizuno T; Hayashi T; Shimabukuro Y; Murase M; Hayashi H; Ishikawa K; Takahashi K; Yuzawa Y; Yamada S; Nagamatsu T
Oncology; 2016; 90(6):313-20. PubMed ID: 27225867
[TBL] [Abstract][Full Text] [Related]
8. Subclinical chronic kidney disease modifies the diagnosis of experimental acute kidney injury.
Succar L; Pianta TJ; Davidson T; Pickering JW; Endre ZH
Kidney Int; 2017 Sep; 92(3):680-692. PubMed ID: 28476556
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin and AKI: an ongoing battle with new perspectives-a narrative review.
Volovat S; Apetrii M; Stefan A; Vlad C; Voroneanu L; Hogas M; Haisan A; Volovat C; Hogas S
Int Urol Nephrol; 2023 May; 55(5):1205-1209. PubMed ID: 36508071
[TBL] [Abstract][Full Text] [Related]
10. Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity.
Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M
Iran J Kidney Dis; 2015 Jul; 9(4):306-10. PubMed ID: 26174458
[TBL] [Abstract][Full Text] [Related]
11. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study.
Yoshida T; Niho S; Toda M; Goto K; Yoh K; Umemura S; Matsumoto S; Ohmatsu H; Ohe Y
Jpn J Clin Oncol; 2014 Apr; 44(4):346-54. PubMed ID: 24503028
[TBL] [Abstract][Full Text] [Related]
13. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
[TBL] [Abstract][Full Text] [Related]
14. Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity.
Li HY; Yang S; Li JC; Feng JX
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30455396
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for acute kidney injury by non-steroidal anti-inflammatory drugs in patients with hyperuricaemia.
Moon KW; Kim J; Kim JH; Song R; Lee EY; Song YW; Lee EB
Rheumatology (Oxford); 2011 Dec; 50(12):2278-82. PubMed ID: 22019809
[TBL] [Abstract][Full Text] [Related]
16. Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial.
Baek SH; Kim SH; Kim JW; Kim YJ; Lee KW; Na KY
Trials; 2015 May; 16():239. PubMed ID: 26021829
[TBL] [Abstract][Full Text] [Related]
17. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
[TBL] [Abstract][Full Text] [Related]
18. The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia.
Arora P; Davari-Farid S; Pourafkari L; Gupta A; Dosluoglu HH; Nader ND
J Vasc Surg; 2015 Mar; 61(3):720-7. PubMed ID: 25499712
[TBL] [Abstract][Full Text] [Related]
19. Kidney-Targeted Renalase Agonist Prevents Cisplatin-Induced Chronic Kidney Disease by Inhibiting Regulated Necrosis and Inflammation.
Guo X; Xu L; Velazquez H; Chen TM; Williams RM; Heller DA; Burtness B; Safirstein R; Desir GV
J Am Soc Nephrol; 2022 Feb; 33(2):342-356. PubMed ID: 34921111
[TBL] [Abstract][Full Text] [Related]
20. Renal Function is the Main Predictor of Acute Kidney Injury after Endovascular Abdominal Aortic Aneurysm Repair.
Saratzis A; Nduwayo S; Sarafidis P; Sayers RD; Bown MJ
Ann Vasc Surg; 2016 Feb; 31():52-9. PubMed ID: 26658089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
